Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
Nodes: 1975,
Authors: 5409,
Journals: 512,
Outer References: 13295,
Words: 3300
Collection span: 1980 - 2004
View: Overview. Sorted by LCS.
Page 4: 1 2 3 4 5 6 7
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
---|---|---|---|---|---|
901 | 3 | 8 | 1156 2001 BRITISH JOURNAL OF HAEMATOLOGY 115(2):484-485 Biagi JJ; Prince HM Thalidomide is effective for extramedullary relapse of multiple myeloma postallogeneic bone marrow transplantation | 1 | 1 |
902 | 7 | 46 | 1186 2001 ELECTROPHORESIS 22(15):3185-3190 Schoetz G; Trapp O; Schurig V Determination of the enantiomerization barrier of thalidomide by dynamic capillary electrokinetic chromatography | 1 | 4 |
903 | 0 | 0 | 1203 2001 HAEMATOLOGICA 86(4):448-448 Zappasodi P; Lorenzi A; Corso A Thalidomide in refractory myeloma patients: early changes in bone marrow cellularity | 1 | 1 |
904 | 12 | 25 | 1216 2001 ISRAEL MEDICAL ASSOCIATION JOURNAL 3(9):644-648 Kenet G; Wardi J; Avni Y; Aeed H; Shirin H; Zaidel L; Hershkoviz R; Bruck R Amelioration of experimental colitis by thalidomide | 1 | 1 |
905 | 0 | 0 | 1217 2001 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 286(8):909-909 Mitka M Thalidomide battles myeloma | 1 | 0 |
906 | 37 | 44 | 1218 2001 JOINT BONE SPINE 68(6):582-587 Combe B Thalidomide: new indications? | 1 | 3 |
907 | 4 | 10 | 1228 2001 JOURNAL OF INFECTIOUS DISEASES 183(2):343-346 Jacobson JM; Greenspan JS; Spritzler J; Fox L; Fahey JL; Jackson JB; Chernoff M; Wohl DA; Pulvirenti JJ; Hooton TM; Shikuma C; Natl Inst Allergy Infect Dis AIDS Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers | 1 | 3 |
908 | 8 | 27 | 1235 2001 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 298(3):1221-1226 Drenth JPH; Vonk AG; Simon A; Powell R; Van der Meer JWM Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: A randomized, double-blind, placebo-controlled trial | 1 | 7 |
909 | 11 | 21 | 1246 2001 NETHERLANDS JOURNAL OF MEDICINE 59(2):45-49 van de Poel MHW; Pasman PC; Schouten HC The use of thalidomide in chronic refractory graft versus host disease | 1 | 3 |
910 | 1 | 26 | 1248 2001 NEUROTOXICOLOGY AND TERATOLOGY 23(3):255-264 Vorhees CV; Weisenburger WP; Minck DR Neurobehavioral teratogenic effects of thalidomide in rats | 1 | 3 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
911 | 3 | 3 | 1250 2001 NEW ENGLAND JOURNAL OF MEDICINE 345(16):1214-1215 Kudva GC; Collins BT; Dunphy FR Thalidomide for malignant melanoma. | 1 | 2 |
912 | 23 | 55 | 1257 2001 OPHTHALMIC RESEARCH 33(5):256-263 Baatz H; Tonessen B; Prada J; Pleyer U Thalidomide inhibits leukocyte-endothelium interaction in endotoxin-induced uveitis | 1 | 4 |
913 | 8 | 16 | 1260 2001 PEDIATRIC DERMATOLOGY 18(2):143-145 Brik R; Shamali H; Bergman R Successful thalidomide treatment of severe infantile Behcet disease | 1 | 1 |
914 | 6 | 15 | 1280 2002 ACTA DERMATO-VENEREOLOGICA 82(5):384-386 Kolde G; Schulze P; Sterry W Mixed response to thalidomide therapy in adults: Two cases of multisystem Langerhans' cell histiocytosis | 1 | 2 |
915 | 7 | 11 | 1281 2002 AIDS 16(17):2355-2356 Teo S; Noormohamed F; Youle M; Johnson M; Peters B; Stirling D; Thomas S Transient increase in plasma HIV-1 viral load and associated weight gain after thalidomide dosing | 1 | 1 |
916 | 13 | 27 | 1286 2002 AMERICAN HEART JOURNAL 144(5):847-850 Gullestad L; Semb AG; Holt E; Skardal R; Ueland T; Yndestad A; Froland SS; Aukrust P Effect of thalidomide in patients with chronic heart failure | 1 | 4 |
917 | 3 | 3 | 1288 2002 AMERICAN JOURNAL OF HEMATOLOGY 70(3):265-265 Pulik M; Genet P; Lionnet F; Touahri T Thalidomide-associated gynecomasty in a patient with multiple myeloma | 1 | 1 |
918 | 0 | 21 | 1292 2002 ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY 88(4):421-424 Medeiros M; Araujo MI; Guimaraes NS; Freitas LAR; Silva TMC; Carvalho EM Therapeutic response to thalidomide in Melkersson-Rosenthal syndrome: a case report | 1 | 2 |
919 | 27 | 34 | 1297 2002 ANNALS OF PHARMACOTHERAPY 36(3):521-525 Bessmertny O; Pham T Thalidomide use in pediatric patients | 1 | 2 |
920 | 18 | 27 | 1301 2002 ARCHIVOS DE BRONCONEUMOLOGIA 38(10):492-494 Valero FC; Gonzalez VB Lung toxicity due to thalidomide | 1 | 1 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
921 | 11 | 19 | 1316 2002 BJU INTERNATIONAL 89(6):591-595 Douglas ML; Reid JL; Hii SI; Jonsson JR; Nicol DL Renal cell carcinoma may adapt to and overcome anti-angiogenic intervention with thalidomide | 1 | 4 |
922 | 24 | 39 | 1389 2002 BLOOD 100(12):4162-4168 Yaccoby S; Johnson CL; Mahaffey SC; Wezeman MJ; Barlogie B; Epstein J Antimyeloma efficacy of thalidomide in the SCID-hu model | 1 | 6 |
923 | 4 | 4 | 1402 2002 BRITISH JOURNAL OF HAEMATOLOGY 118(1):347-347 Myers B; Dolan G Analysis of durability of response to thalidomide treatment for relapsed myeloma patients | 1 | 1 |
924 | 8 | 12 | 1403 2002 BRITISH JOURNAL OF HAEMATOLOGY 119(1):128-130 Wilson EA; Jobanputra S; Jackson R; Parker AN; McQuaker IG Response to thalidomide in chemotherapy-resistant mantle cell lymphoma: a case report | 1 | 3 |
925 | 80 | 118 | 1415 2002 CANCER INVESTIGATION 20(5-6):835-848 Baidas S; Tfayli A; Bhargava P Thalidomide: An old drug with new clinical applications | 1 | 3 |
926 | 4 | 5 | 1417 2002 CELL SIGNALING, TRANSCRIPTION, AND TRANSLATION AS THERAPEUTIC TARGETS 973:414-418 Jin SH; Il Kim T; Han DS; Shin SK; Kim WH Thalidomide suppresses the interleukin 1 beta-induced NF kappa B signaling pathway in colon cancer cells | 1 | 3 |
927 | 58 | 107 | 1433 2002 CROATIAN MEDICAL JOURNAL 43(3):274-285 Mujagic H; Chabner BA; Mujagic Z Mechanisms of action and potential therapeutic uses of thalidomide | 1 | 2 |
928 | 6 | 38 | 1437 2002 DEVELOPMENTAL DYNAMICS 225(2):186-194 Hansen JM; Gong SG; Philbert M; Harris C Misregulation of gene expression in the redox-sensitive NF-kappa B-dependent limb outgrowth pathway by thalidomide | 1 | 3 |
929 | 13 | 14 | 1443 2002 EUROPEAN JOURNAL OF DERMATOLOGY 12(1):63-65 Frances C; El Khoury S; Gompel A; Becherel PA; Chosidow O; Piette JC Transient secondary amenorrhea in women treated by thalidomide | 1 | 2 |
930 | 5 | 25 | 1444 2002 EUROPEAN JOURNAL OF HEART FAILURE 4(4):455-460 Vescovo G; Ravara B; Angelini A; Sandri M; Carraro U; Ceconi C; Libera LD Effect of thalidomide on the skeletal muscle in experimental heart failure | 1 | 2 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
931 | 19 | 36 | 1445 2002 EUROPEAN JOURNAL OF PHARMACOLOGY 453(2-3):325-334 Thiele A; Bang R; Gutschow M; Rossol M; Loos S; Eger K; Tiegs G; Hauschildt S Cytokine modulation and suppression of liver injury by a novel analogue of thalidomide | 1 | 3 |
932 | 0 | 0 | 1453 2002 GASTROENTEROLOGY 122(4):A194-A194 Bauditz J; Wedel S; Lochs H Thalidomide for treatment of intestinal bleeding: Correlation to VEGF | 1 | 1 |
933 | 0 | 0 | 1457 2002 GUT 50:A4-A4 Khan ZH; Simpson E; Cole AT; Macdonald I; Pye D; Austin A; Freeman JG Oesophageal cancer and cachexia: The effects of thalidomide on weight loss and lean body mass in a sequential (metabolic) study | 1 | 1 |
934 | 13 | 20 | 1461 2002 HAEMATOLOGICA 87(4):344-345 Ribatti D; Vacca A Is thalidomide a true anti-angiogenic molecule in multiple myeloma? | 1 | 1 |
935 | 3 | 10 | 1464 2002 HAEMATOLOGICA 87(8):884-886 Musto P; Falcone A; Sanpaolo G; Bisceglia M; Matera R; Carella AM Thalidomide abolishes transfusion-dependence in selected patients with myelodysplastic syndromes | 1 | 1 |
936 | 13 | 15 | 1467 2002 HAUTARZT 53(11):744-748 Bohmeyer J; Achenbach A; Westenberger M; Stadler R Thalidomide therapy of cutaneous lupus erythematosus | 1 | 1 |
937 | 27 | 44 | 1472 2002 INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY 83(2):99-104 Arrieta O; Guevara P; Tamariz J; Rembao D; Rivera E; Sotelo J Antiproliferative effect of thalidomide alone and combined with carmustine against C6 rat glioma | 1 | 3 |
938 | 6 | 8 | 1498 2002 JOURNAL OF INVESTIGATIVE DERMATOLOGY 119(5):987-988 Gaspari A Thalidomide neurotoxicity in dermatological patients: The next "STEP'' | 1 | 2 |
939 | 6 | 28 | 1502 2002 JOURNAL OF NUCLEAR MEDICINE 43(8):1084-1089 Kinuya S; Kawashima A; Yokoyama K; Koshida K; Konishi S; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N Cooperative effect of radioimmunotherapy and antiangiogenic therapy with thalidomide in human cancer xenografts | 1 | 7 |
940 | 5 | 24 | 1519 2002 LEUKEMIA & LYMPHOMA 43(1):133-137 Strupp C; Aivado M; Germing U; Gattermann N; Haas R Angioimmunoblastic lymphadenopathy (AILD) may respond to thalidomide treatment: Two case reports | 1 | 4 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
941 | 2 | 4 | 1527 2002 MAYO CLINIC PROCEEDINGS 77(12):1395-1395 Crawford CL Thalidomide-induced neuropathy | 1 | 1 |
942 | 1 | 6 | 1529 2002 MEDICAL JOURNAL OF AUSTRALIA 177(5):278-278 McBride W Thalidomide and cancer | 1 | 1 |
943 | 9 | 23 | 1531 2002 MEDICAL ONCOLOGY 19(4):219-226 Srkalovic G; Elson P; Trebisky B; Karam MA; Hussein MA Use of melphalan, thalidomide, and dexamethasone in treatment of refractory and relapsed multiple myeloma | 1 | 2 |
944 | 4 | 11 | 1535 2002 OBSTETRICS AND GYNECOLOGY 99(1):125-128 Ances BM New concerns about thalidomide | 1 | 3 |
945 | 1 | 1 | 1536 2002 ONCOLOGY-NEW YORK 16(1):21-22 Kurstin R Using thalidomide in a patient with epithelioid leiomyosarcoma and Osler-Weber-Rendu disease | 1 | 1 |
946 | 11 | 47 | 1546 2002 PHARMACOTHERAPY 22(8):1019-1028 Cool RM; Herrington JD Thalidomide for the treatment of relapsed and refractory multiple myeloma | 1 | 1 |
947 | 11 | 15 | 1549 2002 REVUE DE MEDECINE INTERNE 23(7):651-656 Claudon A; Dietemann JL; De Compte AH; Hassler P Interest of thalidomide in cutaneo-mucous and hypothalamo-hypophyseal in Langerhans cell histiocytosis. | 1 | 1 |
948 | 1 | 6 | 1564 2003 AMERICAN JOURNAL OF GASTROENTEROLOGY 98(1):221-222 Shurafa M; Kamboj G Thalidomide for the treatment of bleeding angiodysplasias | 1 | 2 |
949 | 3 | 37 | 1565 2003 AMERICAN JOURNAL OF HEMATOLOGY 73(1):48-53 Lee FC; Merchant SH Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide | 1 | 4 |
950 | 8 | 19 | 1580 2003 ANNALS OF PHARMACOTHERAPY 37(7-8):1040-1043 Kaur A; Yu SS; Lee AJ; Chiao TB Thalidomide-induced sinus bradycardia | 1 | 1 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
951 | 151 | 187 | 1581 2003 ANNALS OF PHARMACOTHERAPY 37(9):1307-1320 Nasca MR; Micali G; Cheigh NH; West LE; West DP Dermatologic and nondermatologic uses of thalidomide | 1 | 1 |
952 | 12 | 26 | 1600 2003 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 13(20):3415-3417 Man HW; Corral LG; Stirling DI; Muller GW alpha-fluoro-substituted thalidomide analogues | 1 | 1 |
953 | 13 | 35 | 1666 2003 BONE MARROW TRANSPLANTATION 32(2):165-170 Kulkarni S; Powles R; Sirohi B; Treleaven J; Saso R; Horton C; Atra A; Ortin M; Rudin C; Goyal S; Sankpal S; Meller S; Pinkerton CR; Mehta J; Singhal S Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease | 1 | 2 |
954 | 11 | 28 | 1668 2003 BONE MARROW TRANSPLANTATION 32(6):587-592 Ghobrial IM; Dispenzieri A; Bundy KL; Gastineau DA; Rajkumar SV; Therneau TM; Lacy MQ; Witzig TE; Litzow MR; Christensen BR; Hayman S; Pribula CG; Gertz MA Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma | 1 | 1 |
955 | 3 | 5 | 1678 2003 BRITISH JOURNAL OF HAEMATOLOGY 121(1):191-192 Younis TH Reversible pulmonary hypertension and thalidomide therapy for multiple myeloma | 1 | 2 |
956 | 9 | 20 | 1684 2003 BRITISH JOURNAL OF HAEMATOLOGY 123(3):436-441 Thomas DA; Estey E; Giles FJ; Faderl S; Cortes J; Keating M; O'Brien S; Albitar M; Kantarjian H Single agent thalidomide in patients with relapsed or refractory acute myeloid leukaemia | 1 | 2 |
957 | 49 | 86 | 1707 2003 CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 46:S49-S57 Macpherson GR; Franks M; Tomoaia-Cotisel A; Ando Y; Price DK; Figg WD Current status of thalidomide and its role in the treatment of metastatic prostate cancer | 1 | 2 |
958 | 11 | 18 | 1710 2003 DERMATOLOGY 206(4):381-383 Kolivras A; De Maubeuge J; Andre J; Song M Thalidomide in refractory vulvar ulcerations associated with Crohn's disease | 1 | 1 |
959 | 6 | 42 | 1712 2003 DIABETOLOGIA 46(12):1669-1675 Bosco AA; Lerario AC; Santos RF; Wajchenberg BL Effect of thalidomide and rosiglitazone on the prevention of diabetic retinopathy in streptozotocin-induced diabetic rats | 1 | 1 |
960 | 5 | 10 | 1729 2003 INTERNAL MEDICINE 42(7):605-608 Hayashi T; Yamaguchi I; Saitoh H; Takagi M; Nonaka Y; Nomura T Thalidomide treatment for immunoglobulin D multiple myeloma in a patient on chronic hemodialysis | 1 | 2 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
961 | 14 | 32 | 1736 2003 INVESTIGATIONAL NEW DRUGS 21(3):359-366 Dal Lago L; Richter MF; Cancela AI; Fernandes SA; Jung KT; Rodrigues AC; Dalla Costa T; Di Leone LP; Schwartsmann G Phase II trial and pharmacokinetic study of thalidomide in patients with metastatic colorectal cancer | 1 | 1 |
962 | 51 | 94 | 1747 2003 JOURNAL OF CLINICAL ONCOLOGY 21(23):4444-4454 Dimopoulos MA; Anagnostopoulos A; Weber D Treatment of plasma cell dyserasias with thalidomide and its derivatives | 1 | 2 |
963 | 19 | 46 | 1752 2003 JOURNAL OF INVESTIGATIVE DERMATOLOGY 121(5):1060-1065 Deng L; Ding WH; Granstein RD Thalidomide inhibits tumor necrosis factor-alpha production and antigen presentation by Langerhans cells | 1 | 1 |
964 | 1 | 27 | 1753 2003 JOURNAL OF MEDICAL GENETICS 40(7):473-478 Kohlhase J; Schubert L; Liebers M; Rauch A; Becker K; Mohammed SN; Newbury-Ecob R; Reardon W Mutations at the SALL4 locus on chromosome 20 result in a range of clinically overlapping phenotypes, including Okihiro syndrome, Holt-Oram syndrome, acro-renal-ocular syndrome, and patients previously reported to represent thalidomide embryopathy | 1 | 6 |
965 | 11 | 25 | 1754 2003 JOURNAL OF MEDICINAL CHEMISTRY 46(18):3793-3799 Luzzio FA; Mayorov AV; Ng SSW; Kruger EA; Figg WD Thalidomide metabolites and analogues. 3. Synthesis and antiangiogenic activity of the teratogenic and TNF alpha-modulatory thalidomide analogue 2-(2,6-dioxopiperidine-3-yl)phthalimidine | 1 | 1 |
966 | 5 | 8 | 1782 2003 LEUKEMIA 17(8):1669-1670 Visani G; Mele A; Malagola M; Isidori A; Finelli C; Piccaluga PP Sequential combination of thalidomide and erythropoietin determines transfusion independence and disease control in idiopathic myelofibrosis previously insensitive to both drugs used as single agents | 1 | 1 |
967 | 12 | 13 | 1788 2003 LEUKEMIA & LYMPHOMA 44(6):989-991 Abdalla SH; Mahmoud S Thalidomide in relapsed or refractory multiple myeloma: How much and for how long? | 1 | 1 |
968 | 12 | 17 | 1791 2003 LEUKEMIA & LYMPHOMA 44(7):1147-1149 Wechalekar AD; Chen CI; Sutton D; Reece D; Voralia M; Stewart AK Intermediate dose thalidomide (200 mg daily) has comparable efficacy and less toxicity than higher doses in relapsed multiple myeloma | 1 | 1 |
969 | 6 | 10 | 1801 2003 NEUROLOGY 60(1):130-132 Gupta A; Cohen BH; Ruggieri P; Packer RJ; Phillips PC Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1 | 1 | 4 |
970 | 2 | 3 | 1803 2003 NEW ENGLAND JOURNAL OF MEDICINE 348(18):1821-1822 Morgan AE; Smith WK; Levenson JL Reversible dementia due to thalidomide therapy for multiple myeloma | 1 | 1 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
971 | 44 | 67 | 1806 2003 ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS 95(5):576-585 Hegarty A; Hodgson T; Porter S Thalidomide for the treatment of recalcitrant oral Crohn's disease and orofacial granulomatosis | 1 | 2 |
972 | 11 | 22 | 1808 2003 PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS 33:15-18 Rodeghiero F; Elice F Thalidomide and thrombosis | 1 | 2 |
973 | 69 | 104 | 1826 2003 SWISS MEDICAL WEEKLY 133(5-6):77-87 von Moos R; Stolz R; Cerny T; Gillessen S Thalidomide: from tragedy to promise | 1 | 1 |
974 | 11 | 28 | 1840 2004 ANNALS OF ONCOLOGY 15(1):134-138 Zervas K; Dimopoulos MA; Hatzicharissi E; Anagnostopoulos A; Papaioannou A; Mitsouli C; Panagiotidis P; Korantzis J; Tzilianos M; Maniatis A; Greek Myeloma Study Grp Primary treatment of multiple myeloma with thalidomide, vincristine, liposomal doxorubicin and dexamethasone (T-VAD doxil): a phase II multicenter study | 1 | 1 |
975 | 24 | 47 | 1857 2004 BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY 71(1):1-16 Teo SK; Denny KH; Stirling DI; Thomas SD; Morseth SL; Hoberman AM Effects of thalidomide on reproductive function and early embryonic development in male and female New Zealand white rabbits | 1 | 1 |
976 | 32 | 40 | 1867 2004 BRITISH JOURNAL OF CANCER 90(5):955-961 Bartlett JB; Michael A; Clarke IA; Dredge K; Nicholson S; Kristeleit H; Polychronis A; Pandha H; Muller GW; Stirling DI; Zeldis J; Dalgleish AG Phase 1 study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers | 1 | 1 |
977 | 6 | 23 | 1883 2004 CHEMICAL & PHARMACEUTICAL BULLETIN 52(4):498-499 Shimazawa R; Sano H; Tanatani A; Miyachi H; Hashimoto Y Thalidomide as a nitric oxide synthase inhibitor and its structural development | 1 | 1 |
978 | 42 | 65 | 1890 2004 CLINICAL PHARMACOKINETICS 43(5):311-327 Teo SK; Colburn WA; Tracewell WG; Kook KA; Stirling DI; Jaworsky MS; Scheffler MA; Thomas SD; Laskin OL Clinical pharmacokinetics of thalidomide | 1 | 1 |
979 | 17 | 32 | 1924 2004 JOURNAL OF CLINICAL ONCOLOGY 22(16):3269-3276 Schey SA; Fields P; Bartlett JB; Clarke IA; Ashan G; Knight RD; Streetly M; Dalgleish AG Phase I study of an immunomodulatory thalidomide analog, CC-4047, in relapsed or refractory multiple myeloma | 1 | 1 |
980 | 11 | 40 | 1945 2004 LEUKEMIA 18(3):624-627 Kumar S; Witzig TE; Dispenzieri A; Lacy MQ; Wellik LE; Fonseca R; Lust JA; Gertz MA; Kyle RA; Greipp PR; Rajkumar SV Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma | 1 | 1 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
981 | 12 | 22 | 1955 2004 MAYO CLINIC PROCEEDINGS 79(7):875-882 Richardson P; Schlossman R; Jagannath S; Alsina M; Desikan R; Blood E; Weller E; Mitsiades C; Hideshima T; Davies F; Doss D; Freeman A; Bosch J; Patin J; Knight R; Zeldis J; Dalton W; Anderson K Thalidomide for patients with relapsed multiple myeloma after high-dose chemotherapy and stem cell transplantation: Results of an open-label Multicenter phase 2 study of efficacy, toxicity, and biological activity | 1 | 1 |
982 | 21 | 42 | 1956 2004 MAYO CLINIC PROCEEDINGS 79(7):883-889 Mesa RA; Elliott MA; Schroeder G; Tefferi A Durable responses to thalidomide-based drug therapy for myelofibrosis with myeloid metaplasia | 1 | 1 |
983 | 7 | 10 | 1967 2004 NEUROLOGY 62(12):2288-2290 Briani C; Zara G; Rondinone R; Della Libera S; Ermani M; Ruggero S; Ghirardello A; Zampieri S; Doria A Thalidomide neurotoxicity - Prospective study in patients with lupus erythematosus | 1 | 1 |
984 | 7 | 10 | 1968 2004 NEUROLOGY 62(12):2291-2293 Cavaletti G; Beronio A; Reni L; Ghiglione E; Schenone A; Briani C; Zara G; Cocito D; Isoardo G; Ciaramitaro P; Plasmati R; Pastorelli F; Frigo M; Piatti M; Carpo M Thalidomide sensory neurotoxicity - A clinical and neurophysiologic study | 1 | 1 |
985 | 0 | 28 | 3 1980 INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY 18:403-409 KLASINC L; TRINAJSTIC N; KNOP JV APPLICATION OF PHOTOELECTRON-SPECTROSCOPY TO BIOLOGICALLY-ACTIVE MOLECULES AND THEIR CONSTITUENT PARTS .8. THALIDOMIDE | 0 | 0 |
986 | 0 | 0 | 4 1981 ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 181(MAR):68-MEDI HASSAN KM; AGRAWAL KC; HASTINGS RC ANTI-INFLAMMATORY - IMMUNOSUPPRESSIVE THALIDOMIDE ANALOGS | 0 | 0 |
987 | 0 | 36 | 8 1981 ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH 31-1(2):315-320 FLOHE L; DRAEGER E; FRANKUS E; GRAUDUMS I; GUNZLER WA; HELM FC; KUUTTISAVOLAINEN ER STUDIES ON THE HYPOTHETICAL RELATIONSHIP OF THALIDOMIDE-INDUCED EMBRYOPATHY AND COLLAGEN BIOSYNTHESIS | 0 | 10 |
988 | 0 | 39 | 9 1981 ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH 31-1(6):941-949 HELM FC; FRANKUS E; FRIDERICHS E; GRAUDUMS I; FLOHE L COMPARATIVE TERATOLOGICAL INVESTIGATION OF COMPOUNDS STRUCTURALLY AND PHARMACOLOGICALLY RELATED TO THALIDOMIDE | 0 | 54 |
989 | 0 | 7 | 12 1981 DERMATOLOGICA 163(2):145-150 SHESKIN J; GORODETSKY R; WEINREB A; LOEWINGER E IRON CONTENT OF SKIN BEFORE AND AFTER THALIDOMIDE TREATMENT OF LEPRA REACTION - A PRELIMINARY-REPORT | 0 | 5 |
990 | 0 | 0 | 13 1981 ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY 52(3):S7-S7 LIPINSKI CG; WEISSER J PATHOLOGICAL EEG FINDINGS IN ADOLESCENTS WITH SEVERE SEQUELAE AFTER THALIDOMIDE EMBRYOPATHY | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
991 | 0 | 0 | 15 1981 FEDERATION PROCEEDINGS 40(3):668-668 GORDON GB; SPIELBERG SP; BLAKE DA; BALASUBRAMANIAN V THALIDOMIDE TERATOGENESIS - EVIDENCE FOR A TOXIC ARENE OXIDE METABOLITE | 0 | 0 |
992 | 0 | 2 | 16 1981 INTERNATIONAL JOURNAL OF DERMATOLOGY 20(3):220-220 JOPLING WH THALIDOMIDE | 0 | 0 |
993 | 0 | 0 | 17 1981 INTERNATIONAL JOURNAL OF DERMATOLOGY 20(3):220-220 SHESKIN J THALIDOMIDE - REPLY | 0 | 0 |
994 | 0 | 0 | 18 1981 INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES 49(4):511-512 PIPER LM; AGRAWAL KC; HASTINGS RC ANTI-INFLAMMATORY IMMUNOSUPPRESSIVE THALIDOMIDE ANALOGS - SCREENING | 0 | 0 |
995 | 0 | 0 | 19 1981 INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES 49(4):512-512 AGRAWAL KC; HASSAN KM; HASTINGS RC STRUCTURE ACTIVITY RELATIONSHIP STUDIES OF THALIDOMIDE ANALOGS AS ANTI-INFLAMMATORY AND IMMUNOSUPPRESSIVE AGENTS | 0 | 0 |
996 | 0 | 0 | 20 1981 JOURNAL OF POST KEYNESIAN ECONOMICS 3(3):459-462 WEINTRAUB S THE CARTER ECONOMIC COUNCILS THALIDOMIDE TIP | 0 | 0 |
997 | 1 | 1 | 22 1981 LANCET 2(8245):510-511 [Anon] THALIDOMIDE - 20 YEARS ON | 0 | 0 |
998 | 0 | 1 | 24 1981 POLITICAL QUARTERLY 52(1):135-136 STREET H THE SUNDAY-TIMES THALIDOMIDE CASE - CONTEMPT OF COURT AND THE FREEDOM OF THE PRESS - ROSEN,M | 0 | 0 |
999 | 0 | 32 | 27 1981 REHABILITATION 20(3):128-132 WEINWURMKRAUSE EM PARTNERSHIP AND SEXUALITY OF THALIDOMIDE-AFFECTED YOUNG-PEOPLE | 0 | 0 |
1000 | 0 | 18 | 28 1981 REHABILITATION 20(4):159-164 WEINWURMKRAUSE EM THE SITUATION OF THALIDOMIDE-AFFECTED YOUNG-PEOPLE IN CHOOSING AN OCCUPATION | 0 | 2 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1001 | 0 | 0 | 30 1981 TERATOLOGY 23(2):A51-A51 MCCREDIE J THALIDOMIDE AND THE NEURAL CREST | 0 | 0 |
1002 | 0 | 0 | 31 1981 TERATOLOGY 23(2):A63-A64 STEPHENS TD; MCNULTY TR IS THALIDOMIDE EMBRYOPATHY A RESULT OF NEUROPATHY - NO | 0 | 0 |
1003 | 0 | 22 | 41 1982 ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH 32-1(6):613-620 FRIDERICHS E STUDIES ON THE CNS ACTIVITY PROFILE OF THALIDOMIDE ANALOGS | 0 | 8 |
1004 | 0 | 2 | 42 1982 ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH 32-2(8):898-898 FRANKUS E; FRIDERICHS E; GRAUDUMS I; HELM FC CHEMICAL-STRUCTURE, TERATOGENICITY AND PHARMACOLOGICAL ACTIVITY OF THALIDOMIDE RELATED-COMPOUNDS | 0 | 1 |
1005 | 0 | 1 | 51 1982 PRAXIS DER KINDERPSYCHOLOGIE UND KINDERPSYCHIATRIE 31(6):250-250 BIERMANN G THE ADOLESCENCE OF THALIDOMIDE DAMAGED CHILDREN - GERMAN - JOCHMUS,I, SCHMIDT,GM, LOHMAR,L, LOHMAR,W | 0 | 0 |
1006 | 0 | 0 | 52 1982 TERATOLOGY 25(2):A28-A29 BLAKE DA; GORDON GB; SPIELBERG SP THE ROLE OF METABOLIC-ACTIVATION IN THALIDOMIDE TERATOGENESIS | 0 | 0 |
1007 | 1 | 2 | 53 1982 TERATOLOGY 25(2):A40-A40 FLINT OP THE EFFECT OF THALIDOMIDE ON MICROMASS CULTURES OF EMBRYONIC RAT-CELLS | 0 | 0 |
1008 | 0 | 0 | 55 1982 TERATOLOGY 25(2):A61-A61 MCBRIDE WG; VARDY P; STOKES PA THE MECHANISM OF THALIDOMIDE TERATOGENISM IN THE RABBIT LIMB | 0 | 0 |
1009 | 0 | 0 | 56 1982 TERATOLOGY 25(2):A75-A75 SHEPARD TH; SHIOTA K BIOACTIVATION OF THALIDOMIDE BY A MONKEY LIVER FRACTION IN A RAT LIMB CULTURE SYSTEM | 0 | 0 |
1010 | 0 | 0 | 57 1982 TERATOLOGY 26(1):A4-A4 TSUCHIYA K THALIDOMIDE EMBRYOPATHY AND ITS ALLIED CONDITIONS IN JAPAN | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1011 | 0 | 0 | 58 1982 TERATOLOGY 26(1):A17-A17 MIKAMI T; MATSUBARA Y; YAMANAKA H; SUZUKI Y TERATOGENIC EFFECTS OF THALIDOMIDE IN RABBITS - (3) THE DEVELOPMENTAL PROCESSES OF DYSRAPHIC MALFORMATIONS IN JW-NIBS RABBITS | 0 | 0 |
1012 | 0 | 0 | 59 1982 TERATOLOGY 26(3):A19-A19 OCKENFELS H; KOCHERBECKER U; KOCHER W EFFECTS OF SINGLE AND COMBINED ACTION OF A HYDROLYSIS PRODUCT OF THALIDOMIDE AND THE SURFACTANT TWEEN 20 IN MICE | 0 | 0 |
1013 | 0 | 0 | 60 1983 ACTA NEUROLOGICA SCANDINAVICA 68(3):184-184 SCHRODER JM; MATTHIESEN T EXPERIMENTAL THALIDOMIDE NEUROPATHY - THE MORPHOLOGICAL CORRELATE OF REDUCED CONDUCTION-VELOCITY | 0 | 0 |
1014 | 0 | 0 | 61 1983 AMERICAN JOURNAL OF PRIMATOLOGY 4(4):336-336 NEWMAN L; HENDRICKX A FETAL DEVELOPMENT IN THE NORMAL AND THALIDOMIDE-EXPOSED THICK-TAILED BUSHBABY | 0 | 0 |
1015 | 0 | 0 | 65 1983 AUSTRALIAN PAEDIATRIC JOURNAL 19(3):198-198 NORTH K; MCCREDIE J THALIDOMIDE DEFORMITIES AND THEIR NERVE SUPPLY | 0 | 0 |
1016 | 0 | 0 | 67 1983 BRITISH JOURNAL OF DERMATOLOGY 108(1):109-109 HASPER MF THE EFFECT OF THALIDOMIDE IN THE TREATMENT OF LUPUS-ERYTHEMATOSUS | 0 | 0 |
1017 | 2 | 3 | 70 1983 BRITISH JOURNAL OF DERMATOLOGY 109(4):479-480 NAAFS B; FABER WR THALIDOMIDE | 0 | 0 |
1018 | 0 | 20 | 71 1983 BRITISH MEDICAL JOURNAL 286(6360):199-202 VENNING GR IDENTIFICATION OF ADVERSE REACTIONS TO NEW DRUGS .1. WHAT HAVE BEEN THE IMPORTANT ADVERSE REACTIONS SINCE THALIDOMIDE | 0 | 59 |
1019 | 1 | 2 | 73 1983 BRITISH MEDICAL JOURNAL 287(6400):1225-1225 WALKER W; LEWIS HBM; ALBERTRECHT F EFFECT OF THALIDOMIDE ON OROGENITAL ULCERATION | 0 | 0 |
1020 | 0 | 0 | 77 1983 CHELSEA (42-4):237-237 RIDLAND J THE 'THALIDOMIDE KIDS ON TELEVISION (1978)' | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1021 | 0 | 5 | 78 1983 CLINICAL AND EXPERIMENTAL DERMATOLOGY 8(2):208-209 LAURET P THALIDOMIDE AND THE MANAGEMENT OF LUPUS-ERYTHEMATOSUS | 0 | 1 |
1022 | 0 | 0 | 79 1983 CLINICAL RESEARCH 31(2):A266-A266 MONCADA B; BARANDA ML; LOREDO C; URBINA R; GONZALEZAMARO R; HERNANDEZRODRIGUEZ H THALIDOMIDE AND LEPRA REACTION - DOES THE DRUG AFFECT LYMPHOCYTE POPULATIONS | 0 | 0 |
1023 | 0 | 0 | 83 1983 ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY 56(3):S128-S128 LUDOLPH A; SCHULTE J; BRUNE GG ELECTRO-PHYSIOLOGICAL STUDIES CONCERNING THE REVERSIBILITY OF POLYNEUROPATHIES DUE TO THALIDOMIDE THERAPY OF LUPUS ERYTHEMATODES DISCOIDES | 0 | 0 |
1024 | 2 | 6 | 84 1983 GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE 7(8-9):751-751 COUZIGOU P; DOUTRE MS; HOUDEE G; RICHARDMOLARD B; FLUERY B; AMOURETTI M; BEYLOT C; BERAUD C THALIDOMIDE IN THE TREATMENT OF BEHCETS SYNDROME | 0 | 9 |
1025 | 0 | 0 | 89 1983 KEMISK TIDSKRIFT 95(12):74-74 LEVERBECK K SECRET TEST REVEALS THE MUTAGENIC EFFECT OF THALIDOMIDE | 0 | 0 |
1026 | 0 | 0 | 91 1983 NEW SCIENTIST 99(1371):457-457 MACKENZIE D SECRET TESTS SAY THALIDOMIDE IS MUTAGENIC | 0 | 0 |
1027 | 0 | 1 | 92 1983 NEW SCIENTIST 100(1378):49-49 FLOHE L THALIDOMIDE | 0 | 0 |
1028 | 0 | 37 | 93 1983 PERSPECTIVES IN BIOLOGY AND MEDICINE 27(1):93-106 WYATT HV DID THALIDOMIDE PROMOTE POLIOMYELITIS FOLLOWING ORAL POLIOVIRUS VACCINATION IN WEST-BERLIN IN 1960 | 0 | 4 |
1029 | 0 | 6 | 97 1983 TERATOLOGY 27(2):A29-A30 BECK SL PAUCITY OF POSTNATAL EFFECTS ON CD-1 MOUSE SKELETON OF PRENATAL EXPOSURE TO CAPTAN, THALIDOMIDE, CORTISONE, OR DIPHENYLHYDANTOIN | 0 | 3 |
1030 | 0 | 0 | 98 1983 TERATOLOGY 27(2):A33-A33 BRAUN AG; WEINREB SL METABOLITES OF THALIDOMIDE ANALOGS INHIBIT ATTACHMENT OF CELLS TO CONCANAVALIN A COATED SURFACES | 0 | 2 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1031 | 0 | 0 | 99 1983 TERATOLOGY 27(2):A80-A80 THEISEN CT THALIDOMIDE DYSMELIA IN RHESUS-MONKEYS - AN OVERVIEW | 0 | 0 |
1032 | 0 | 0 | 101 1983 TERATOLOGY 28(1):A13-A14 MIKAMI T; MATSUBARA Y; YAMANAKA H; SUZUKI Y TERATOGENIC EFFECTS OF THALIDOMIDE IN RABBITS .4. DYSRAPHISM OF THE ANTERIOR NEUROPORE IN JW-NIBS RABBIT EMBRYOS ANALYZED BY SEM | 0 | 0 |
1033 | 0 | 0 | 102 1983 ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE 121(4):526-526 RUFFING L DISTURBANCES OF DISK DIFFERENTIATION DUE TO THALIDOMIDE | 0 | 0 |
1034 | 0 | 0 | 105 1984 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 111(3):289-290 VIGNOLLY B; GENIAUX M; ROMMEL A; TEXIER L BEHCET DISEASE, NODOUS ERYTHEMA AND THALIDOMIDE | 0 | 0 |
1035 | 0 | 1 | 111 1984 BRITISH MEDICAL JOURNAL 289(6456):1424-1424 HASSAN EM; GOSSMAN HH THALIDOMIDE AND MULTIPLE CEREBRAL ANEURYSMS - FORTUITOUS OR CAUSAL ASSOCIATION | 0 | 0 |
1036 | 0 | 0 | 112 1984 CLINICAL RESEARCH 32(2):A569-A569 ARONSON IK; YU R; WEST DP; VANDENBROEK H; ANTEL J THALIDOMIDE INDUCED PERIPHERAL NEUROPATHY - EFFECT OF SERUM FACTOR ON NERVE CULTURES | 0 | 0 |
1037 | 0 | 0 | 113 1984 CLINICAL RESEARCH 32(2):A603-A603 MILLIKAN LE; DOLL NJ; BARNHILL RL; HASTINGS RC; SALVAGGIO JE THE INVITRO EFFECTS OF THALIDOMIDE ON HUMAN POLYMORPHONUCLEAR LEUKOCYTE FUNCTION | 0 | 0 |
1038 | 1 | 33 | 116 1984 GEBURTSHILFE UND FRAUENHEILKUNDE 44(4):243-248 MUHLENSTEDT D; SCHWARZ M GYNECOLOGICAL AND ENDOCRINOLOGICAL INVESTIGATIONS IN WOMEN DAMAGED BY THALIDOMIDE | 0 | 0 |
1039 | 0 | 5 | 122 1984 LANCET 2(8396):205-206 [Anon] DEBENDOX IS NOT THALIDOMIDE | 0 | 0 |
1040 | 0 | 0 | 126 1984 TERATOLOGY 29(2):A19-A20 BRAUN AG; COLLINS M; HARDING F; WEINREB S FACTORS INFLUENCING THE ACTIVATION OF THALIDOMIDE TO A PRODUCT INHIBITING ATTACHMENT OF TUMOR-CELLS TO LECTIN COATED SURFACES | 0 | 1 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1041 | 0 | 0 | 127 1984 TERATOLOGY 30(1):A26-A26 KANNO O; SAITO T; ASAKA A ELECTROENCEPHALOGRAPHIC STUDY ON THALIDOMIDE EMBRYOPATHY | 0 | 0 |
1042 | 0 | 0 | 128 1984 TERATOLOGY 30(1):A26-A26 IWAKURA H; YOSHIDA K; OGAWA T PHYSICAL-EXAMINATION OF THALIDOMIDE EMBRYOPATHY PATIENTS - PROBLEMS OF MOTOR DYSFUNCTION | 0 | 0 |
1043 | 0 | 0 | 129 1984 TERATOLOGY 30(1):A26-A27 SAITO T; ASAKA A; KANNO O; KIDA M PSYCHOLOGICAL-TESTS AND A STUDY OF SOCIAL-ADJUSTMENT OF PATIENTS WITH THALIDOMIDE EMBRYOPATHY | 0 | 0 |
1044 | 0 | 0 | 130 1984 TERATOLOGY 30(1):A27-A27 KIDA M MEDICAL-EXAMINATION OF THALIDOMIDE-EMBRYOPATHY - METHODOLOGY AND SUMMARY | 0 | 0 |
1045 | 0 | 0 | 131 1984 TERATOLOGY 30(1):A36-A36 MATSUMOTO Y; HAMADA Y FINDINGS OF THE UROGENITAL ORGAN SYSTEMS OF THALIDOMIDE EMBRYOPATHY | 0 | 0 |
1046 | 0 | 0 | 132 1984 TERATOLOGY 30(1):A36-A36 ARIMOTO H OCULAR FINDINGS OF THALIDOMIDE EMBRYOPATHY | 0 | 0 |
1047 | 0 | 0 | 133 1984 TERATOLOGY 30(1):A36-A36 TANAKA Y THALIDOMIDE-INDUCED OTOLARYNGOLOGICAL DEFECTS | 0 | 0 |
1048 | 0 | 0 | 134 1984 TERATOLOGY 30(1):A37-A37 KIKUCHI S ANOMALIES OF THE ORAL AND MAXILLO-FACIAL REGIONS IN THALIDOMIDE EMBRYOPATHY (JAPAN) | 0 | 0 |
1049 | 0 | 0 | 135 1985 ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 189(APR-):21-MEDI KING BT; AGRAWAL KC; MORALES MJ; HASTINGS RC ANTIINFLAMMATORY IMMUNOSUPPRESSIVE THALIDOMIDE ANALOGS | 0 | 0 |
1050 | 0 | 0 | 137 1985 AMERICAN JOURNAL OF PRIMATOLOGY 8(4):355-355 NEWMAN L; HENDERICKX A INTERSPECIES VARIATION IN FETAL OTOTEMPOROMANDIBULAR ANOMALIES FOLLOWING MATERNAL THALIDOMIDE EXPOSURE | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1051 | 0 | 0 | 138 1985 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 112(1):90-90 DELSOL G; DUPRE A; VIRABEN R ROSAI-DORFMAN HISTIOCYTOSIS IN A PURE CUTANEOUS FORM - THE THERAPEUTIC USE OF THALIDOMIDE | 0 | 0 |
1052 | 4 | 18 | 139 1985 ARCHIVOS DE INVESTIGACION MEDICA 16(2):139-143 AVALOSDIAZ E; GUZMANENRIQUEZ L; LOPEZROBLES E; HERRERAESPARZA R INHIBITORY EFFECT OF ENDOCYTOSIS IN POLIMORPHONUCLEAR CELLS CAUSED BY THALIDOMIDE | 0 | 0 |
1053 | 0 | 0 | 141 1985 AUSTRALIAN PAEDIATRIC JOURNAL 21(4):295-295 DUNLOP GM; MCCREDIE J QUANTITATIVE NEUROLOGICAL CHANGES IN THALIDOMIDE EMBRYOPATHY | 0 | 0 |
1054 | 1 | 1 | 145 1985 BRITISH JOURNAL OF RHEUMATOLOGY 24(1):95-96 JENKINS JS; POWELL RJ; MAURICE P; LITTLEWOOD S; ALLEN BR THALIDOMIDE IN THE TREATMENT OF OROGENITAL ULCERATION | 0 | 0 |
1055 | 0 | 0 | 146 1985 ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY 61(3):S174-S174 KANNO O; KAZAMATSURI H ELECTROENCEPHALOGRAPHIC STUDY ON THALIDOMIDE EMBRYOPATHY | 0 | 0 |
1056 | 0 | 42 | 147 1985 EUROPEAN JOURNAL OF PHARMACOLOGY 119(1-2):39-46 YOUDIM MBH; ASHKENAZI R SEROTONERGIC INVOLVEMENT IN PHARMACOLOGICAL ACTION OF THE ANXIOLYTIC-SEDATIVES THALIDOMIDE AND SUPIDIMIDE | 0 | 1 |
1057 | 0 | 8 | 148 1985 EXPERIMENTAL ANIMALS 34(3):295-302 MATSUBARA Y; MIKAMI T TERATOGENIC POTENTIALITY OF SINGLE DOSE OF THALIDOMIDE IN JW-NIBS RABBITS | 0 | 1 |
1058 | 0 | 0 | 149 1985 FEDERATION PROCEEDINGS 44(6):1881-1881 VOGELSANG G; GORDON G; HORWITZ L; SANTOS G; HESS A IMMUNOSUPPRESSIVE ACTIVITY OF THALIDOMIDE | 0 | 2 |
1059 | 2 | 2 | 151 1985 INTERNATIONAL JOURNAL OF DERMATOLOGY 24(9):616-616 GROSSHANS EM DISCOID LUPUS-ERYTHEMATOSUS - THALIDOMIDE OR VITAMIN-E | 0 | 0 |
1060 | 1 | 4 | 152 1985 INTERNATIONAL JOURNAL OF DERMATOLOGY 24(9):616-616 AYRES S DISCOID LUPUS-ERYTHEMATOSUS - THALIDOMIDE OR VITAMIN-E | 0 | 1 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1061 | 0 | 0 | 153 1985 INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES 53(1):165-166 SHANNON EJ; TRUMAN RW; CHRISTY SA; VADIEE R; HASTINGS RC EFFECT OF THALIDOMIDE ON INDUCTION OF ANTIBODY-SYNTHESIS IN MICE TO A T-INDEPENDENT ANTIGEN - DNP FICOLL | 0 | 0 |
1062 | 1 | 20 | 155 1985 JOURNAL OF CRANIOFACIAL GENETICS AND DEVELOPMENTAL BIOLOGY 5(2):147-157 NEWMAN LM; HENDRICKX AG TEMPOROMANDIBULAR MALFORMATIONS IN THE BONNET MONKEY (MACACA-RADIATA) FETUS FOLLOWING MATERNAL INGESTION OF THALIDOMIDE | 0 | 4 |
1063 | 2 | 9 | 157 1985 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 13(2):304-305 MIYACHI Y; NIWA Y THALIDOMIDE AND OXYGEN INTERMEDIATES | 0 | 0 |
1064 | 1 | 3 | 158 1985 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 13(2):305-305 BARNHILL RL THALIDOMIDE AND OXYGEN INTERMEDIATES - REPLY | 0 | 0 |
1065 | 0 | 0 | 167 1985 NEW SOCIETY 74(1196):369-371 CAUDREY A THALIDOMIDE GENERATION | 0 | 0 |
1066 | 0 | 4 | 168 1985 PEDIATRIC RESEARCH 19(4):A324-A324 GARDNER LI; WELSHSLOAN J; CADY RB PHOCOMELIA OF LEFT LOWER LEG IN AN INFANT WHOSE MOTHER TOOK LARGE DOSES OF PYRIDOXINE (B-6) - DEJA VU OF THE THALIDOMIDE DISASTER | 0 | 0 |
1067 | 0 | 0 | 172 1985 TERATOLOGY 31(3):A68-A68 TESH JM; NEWALL DR TERATOGENIC EFFECTS OF THALIDOMIDE ON RAT EMBRYOS INVITRO | 0 | 1 |
1068 | 0 | 0 | 175 1986 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 113(5):499-499 REVUZ J; COTTENOT F; ORTONNE JP; GUILLAUME JC THALIDOMIDE ON TRIAL | 0 | 0 |
1069 | 2 | 36 | 178 1986 ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH 36-2(7):1138-1141 GUNZLER V; HANAUSKEABEL HM; TSCHANK G; SCHULTEWISSERMANN H IMMUNOLOGICAL EFFECTS OF THALIDOMIDE - INACTIVITY OF THE DRUG AND SEVERAL OF ITS HYDROLYSIS PRODUCTS IN MONONUCLEOCYTE PROLIFERATION TESTS | 0 | 10 |
1070 | 1 | 33 | 183 1986 CURRENT CONTENTS (50):3-11 GARFIELD E TERATOLOGY LITERATURE AND THE THALIDOMIDE CONTROVERSY | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1071 | 1 | 2 | 184 1986 ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY 64(3):P66-P66 SMITH NJ; JENKINS JS; POWELL RJ; ALLEN BR; LITTLEWOOD SM; MAURICE PDL NERVE-CONDUCTION STUDIES IN PATIENTS TAKING THALIDOMIDE | 0 | 0 |
1072 | 0 | 3 | 185 1986 FOOD AND CHEMICAL TOXICOLOGY 24(6-7):635-636 NEWALL DR; TESH JM EMBRYO CULTURE AS AN EARLY SCREEN FOR TERATOGENIC POTENTIAL .2. THALIDOMIDE | 0 | 2 |
1073 | 2 | 3 | 189 1986 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 14(2):283-283 MILLIKAN LE; HASTINGS RC THALIDOMIDE AND LYMPHOCYTE FUNCTION - REPLY | 0 | 1 |
1074 | 0 | 0 | 192 1986 MEDICINA-BUENOS AIRES 46(5):528-528 BOTTASSO OA; MORINI JC; REGGIARDO Z ANTIBODIES AGAINST BCG GLYCOLIPIDS IN LEPROMATOUS PATIENTS TREATED WITH THALIDOMIDE OR LEPROUS KNOTTED ERYTHEMA | 0 | 0 |
1075 | 0 | 0 | 195 1986 TERATOLOGY 33(2):A48-A49 TESH JM; NEWALL DR THALIDOMIDE AND ABNORMAL EMBRYONIC-DEVELOPMENT INVITRO | 0 | 0 |
1076 | 0 | 0 | 196 1986 TERATOLOGY 33(2):A57-A57 SCHMAHL HJ; WINKLER K; HEGER W; BARRACH HJ; NAU H PHARMACOKINETICS OF THE TERATOGENIC AND NONTERATOGENIC THALIDOMIDE ANALOGS EM-12 AND SUPIDIMID IN THE RAT AND MARMOSET MONKEY | 0 | 0 |
1077 | 0 | 0 | 197 1986 TERATOLOGY 34(3):415-415 HEGER W; SAMES K; MERKER HJ; FRANKUS E; GRAUDUMS I; NEUBERT D TERATOGENIC EVALUATION OF A METHYLATED THALIDOMIDE DERIVATIVE IN A PRIMATE SPECIES | 0 | 0 |
1078 | 0 | 0 | 202 1987 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 114(9):1176-1176 CAMBAZARD F; LAFFAY A; VEDRINNE JM; THIVOLET J NEUROLOGICAL COMPLICATIONS OF THALIDOMIDE - STUDY OF 55 DERMATOLOGY PATIENTS (WITH THE EXCEPTION OF HANSENS-DISEASE PATIENTS) | 0 | 0 |
1079 | 0 | 0 | 204 1987 ARCHIVES OF GYNECOLOGY AND OBSTETRICS 242(1-4):944-945 SCHNEIDER HPG; MUHLENSTEDT D; OCHS H PUBERTY, SEXUALITY AND PARTNERSHIP IN YOUNG-PEOPLE WITH THALIDOMIDE-INDUCED DEFORMITIES | 0 | 0 |
1080 | 0 | 0 | 206 1987 CLINICAL RHEUMATOLOGY 6(4):608-609 HAMZA M; HAMZAOUI K; AYED K; ELEUCH M; ZRIBI A THALIDOMIDE AND CELL-MEDIATED IMMUNITY IN BEHCETS-DISEASE | 0 | 2 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1081 | 0 | 0 | 207 1987 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 112(9):365-365 LENZ W THALIDOMIDE-CAUSED BIRTH-DEFECTS | 0 | 0 |
1082 | 0 | 38 | 208 1987 EUROPEAN JOURNAL OF PEDIATRICS 146(1):63-67 SCHAFER KH; KRAMER M INFANTILE HYPERTROPHIC PYLORIC-STENOSIS AFTER PRENATAL EXPOSURE TO THALIDOMIDE | 0 | 0 |
1083 | 0 | 0 | 209 1987 EXPERIMENTAL HEMATOLOGY 15(5):476-476 HULLIN R; VOGELSANG GB; BRUNDRETTE R; COLVIN OM; SANTOS GW; HESS AD INTRACELLULAR BINDING-PROTEINS FOR THALIDOMIDE | 0 | 0 |
1084 | 0 | 0 | 210 1987 JAPANESE JOURNAL OF PSYCHIATRY AND NEUROLOGY 41(2):197-206 KANNO O ELECTROENCEPHALOGRAPHIC STUDY OF 137 PATIENTS WITH THALIDOMIDE EMBRYOPATHY | 0 | 1 |
1085 | 0 | 0 | 214 1987 TERATOLOGY 35(2):A73-A73 HALES BF; JAIN R SPECIES-DIFFERENCES IN THE EFFECTS OF DRUG-METABOLIZING-ENZYMES ON THE TERATOGENICITY OF THALIDOMIDE IN RAT EMBRYO CULTURES | 0 | 1 |
1086 | 0 | 0 | 215 1987 TERATOLOGY 36(1):A8-A9 DEIONGH RU; MCCREDIE J QUANTITATIVE NEUROPATHOLOGY OF THE PERIPHERAL-NERVES IN RABBIT THALIDOMIDE EMBRYOPATHY | 0 | 0 |
1087 | 0 | 0 | 216 1987 TERATOLOGY 36(3):435-435 KIDA M A QUARTER CENTURY IN THE THALIDOMIDE EMBRYOPATHY | 0 | 0 |
1088 | 0 | 2 | 220 1988 ARCHIV DER PHARMAZIE 321(9):577-577 EGER K; BOLEWSKI J; FOLKERS G; GUTBROD O; JALALIAN M; VERSPOHL E; LUPKE NP ALPHA-PHTHALIMIDOADIPINIMIDE - SYNTHESIS, TERATOGENIC PROPERTIES AND EFFECT ON THE CENTRAL NERVOUS-SYSTEM OF A HOMO-THALIDOMIDE | 0 | 0 |
1089 | 0 | 0 | 221 1988 ARCHIV DER PHARMAZIE 321(9):602-602 HESS HR; BLASCHKE G HYDROXYLATION, A STEP IN THALIDOMIDE METABOLIZATION | 0 | 0 |
1090 | 2 | 8 | 229 1988 BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY 95(7):717-719 MAOURIS PG; HIRSCH PJ PREGNANCY IN WOMEN WITH THALIDOMIDE-INDUCED DISABILITIES - CASE-REPORT AND A QUESTIONNAIRE STUDY | 0 | 4 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1091 | 0 | 0 | 240 1988 LEPROSY REVIEW 59(2):184-185 BOURDILLON C THALIDOMIDE IN ERYTHEMA-NODOSUM LEPROSUM (ENL) | 0 | 0 |
1092 | 0 | 0 | 241 1988 NATURE 336(6195):101-101 EWING T THALIDOMIDE SCIENTIST GUILTY OF FRAUD SAYS COMMITTEE | 0 | 2 |
1093 | 0 | 0 | 242 1988 TERATOLOGY 38(2):199-199 MCBRIDE WG; CATALANO A; DUGUID P; HICKS L THE EFFECT OF THALIDOMIDE ADMINISTRATION ON GABA AND OTHER AMINO-ACIDS IN THE MARMOSET EMBRYO | 0 | 0 |
1094 | 1 | 1 | 250 1989 ANAESTHESIA 44(1):69-69 GRAYLING GW; YOUNG PN ANESTHESIA AND THALIDOMIDE-RELATED ABNORMALITIES | 0 | 0 |
1095 | 6 | 11 | 252 1989 BIOCHEMICAL SOCIETY TRANSACTIONS 17(1):114-115 LYNE C; GOWER DB RADIAL THIN-LAYER CHROMATOGRAPHIC AUTORADIOGRAPHIC SCANS OF STEROID-METABOLISM IN THE PRESENCE OF THALIDOMIDE | 0 | 1 |
1096 | 0 | 6 | 255 1989 BRITISH MEDICAL JOURNAL 298(6665):6-6 CHAMBERLAIN G THE OBSTETRIC PROBLEMS OF THE THALIDOMIDE CHILDREN | 0 | 0 |
1097 | 0 | 27 | 269 1990 ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH 40-1(1):32-36 BUCH HP; OMLOR G; KNABE J STEREOSELECTIVE DIFFERENCES OF THE CNS-DEPRESSANT ACTIVITY IN A HOMOLOGOUS SERIES OF 3-ALKYL-THALIDOMIDE ANALOGS | 0 | 5 |
1098 | 0 | 16 | 272 1990 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 115(25):977-979 BROCHELER J; HALFMANN R ANTERIOR SACRAL MENINGOCELE ASSOCIATED WITH THALIDOMIDE EMBRYOPATHY | 0 | 0 |
1099 | 0 | 7 | 273 1990 DICP-THE ANNALS OF PHARMACOTHERAPY 24(5):482-483 JEW LJ; MIDDLETON RK THALIDOMIDE IN ERYTHEMA-NODOSUM LEPROSUM | 0 | 0 |
1100 | 0 | 0 | 276 1990 GAZETTE MEDICALE 97(3):26-27 BELAICH S USE OF THALIDOMIDE IN DERMATOLOGY | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1101 | 0 | 9 | 277 1990 GEBURTSHILFE UND FRAUENHEILKUNDE 50(11):899-900 SCHAEFER C; SPIELMANN H COCAINE AND PREGNANCY - SHADES OF THE THALIDOMIDE TRAGEDY | 0 | 0 |
1102 | 2 | 7 | 288 1990 MEDICAL JOURNAL OF AUSTRALIA 152(3):148-149 BROWN MA; FARRELL C; NEWTON P; CHILD RP THALIDOMIDE, PREGNANCY AND RENAL-FAILURE | 0 | 0 |
1103 | 0 | 2 | 291 1990 PRESSE MEDICALE 19(15):722-722 LIVROZET JM; FRANC C; GRANIER JL; BRETON P; TOURAINE JL THALIDOMIDE TREATMENT OF CHOICE OF APHTHAE IN HIV-INFECTION - REPLY | 0 | 0 |
1104 | 3 | 12 | 295 1990 TERATOLOGY 41(2):241-242 STEPHENS TD PROPOSED MECHANISMS OF ACTION IN THALIDOMIDE EMBRYOPATHY | 0 | 0 |
1105 | 0 | 16 | 298 1990 TOXICOLOGY LETTERS 50(2-3):309-318 SHIOTA K; UWABE C; YAMAMOTO M; ARISHIMA K SUSCEPTIBILITY TO CYCLOPHOSPHAMIDE AND THALIDOMIDE OF FETAL-RAT LIMB BUDS GRAFTED IN ATHYMIC (NUDE) MICE | 0 | 0 |
1106 | 3 | 10 | 304 1991 BRITISH MEDICAL JOURNAL 303(6809):1062-1063 CRAWFORD CL USE OF THALIDOMIDE IN LEPROSY | 0 | 0 |
1107 | 0 | 0 | 307 1991 EXPERIMENTAL HEMATOLOGY 19(6):553-553 VOGELSANG GB; BUJNOVSZKY C; BOUCHER C; LEONG K; JALALIAN M; HESS A; SANTOS GW INVITRO IMMUNOLOGICAL EFFECTS OF THALIDOMIDE | 0 | 0 |
1108 | 0 | 7 | 314 1991 NEURO-OPHTHALMOLOGY 11(1):29-32 HUYGEN PLM; VANRIJN PM; VERHAGEN WIM; CREMERS CWRJ; THEUNISSEN EJJM SUBCORTICAL OPTOKINETIC RESPONSE IN A CASE OF THALIDOMIDE FETOPATHY | 0 | 1 |
1109 | 1 | 6 | 317 1992 ANNALES DE MEDECINE INTERNE 143(7):479-480 LOUZIR B; OTHMANI S; GRITLI N; BEJI M; ZIDI B; MSADDEK F; BOUSSEMA E; BAHRI M ACUTE MYELOID-LEUKEMIA IN A BEHCETS-DISEASE PATIENT UNDER LONG-TERM THALIDOMIDE TREATMENT | 0 | 3 |
1110 | 2 | 2 | 331 1992 LANCET 339(8805):1362-1362 HIGGINS SP; BRADBEER CS THALIDOMIDE - A RESTRICTED ROLE | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1111 | 2 | 9 | 338 1992 TERATOLOGY 46(5):411-413 LIPSON AH THALIDOMIDE RETROSPECTIVE - WHAT DID THE CLINICAL TERATOLOGIST LEARN | 0 | 3 |
1112 | 4 | 37 | 344 1992 ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES 47(1-2):155-169 KOCHERBECKER U; KOCHER W; OCKENFELS H EMBRYOTOXIC INTERACTIONS BETWEEN A HYDROLYSIS PRODUCT OF THALIDOMIDE AND THE SURFACTANT TWEEN 20 IN MICE | 0 | 0 |
1113 | 0 | 0 | 345 1993 ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 206:216-MEDI HE WX; ENGSTROM L; WALKER S; VOGELSANG G; LEONG KW SYNTHESIS OF THALIDOMIDE ANALOGS AND THEIR BIOLOGICAL POTENTIAL FOR TREATMENT OF GRAFT-VERSUS-HOST DISEASE | 0 | 0 |
1114 | 0 | 1 | 347 1993 AMERICAN SCIENTIST 81(5):425-426 HOFFMAN M A 2ND CHANCE FOR THALIDOMIDE | 0 | 0 |
1115 | 0 | 0 | 352 1993 BLOOD 82(10):A421-A421 VOGELSANG GB; COLVIN OM; ALTOMONTE V; PIANTADOSI S; HESS AD; SANTOS GW EFFECT OF THALIDOMIDE DOSE AND PLASMA-LEVEL ON PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE | 0 | 0 |
1116 | 0 | 0 | 355 1993 BRITISH MEDICAL JOURNAL 307(6901):404-404 JOHN D DOCTOR WHO FOUND THALIDOMIDE DANGERS IS STRUCK OFF | 0 | 0 |
1117 | 0 | 1 | 357 1993 CHEMICAL & ENGINEERING NEWS 71(28):5-5 BAUM R THALIDOMIDE BLOCKS VIRUS THAT CAUSES AIDS | 0 | 0 |
1118 | 0 | 1 | 361 1993 GASTROENTEROLOGY 104(4):A683-A683 COHEN LB; PEAREN S; IAZZETTA J THALIDOMIDE FOR INFLAMMATORY BOWEL-DISEASE - A PRELIMINARY-REPORT | 0 | 0 |
1119 | 8 | 15 | 362 1993 GASTROENTEROLOGY 105(3):956-956 RHOTON AJ ROLE FOR THALIDOMIDE IN PRIMARY BILIARY-CIRRHOSIS TREATMENT | 0 | 0 |
1120 | 0 | 0 | 363 1993 INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 34(4):1479-1479 YAN GC; PITTET N; HERBORT CP THE EFFECT OF THALIDOMIDE ON ENDOTOXIN-INDUCED UVEITIS IN RATS | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1121 | 0 | 0 | 366 1993 JOURNAL OF INVESTIGATIVE DERMATOLOGY 100(4):492-492 HARLAND CC; STEVENTON GB; MARSDEN JR THALIDOMIDE INDUCED NEUROPATHY AND DRUG METABOLIC POLYMORPHISM | 0 | 0 |
1122 | 6 | 10 | 368 1993 MEDICINA CLINICA 100(14):557-557 GARCIAALBEA E; CABRERA F; TEJEIRO J; JIMENEZJIMENEZ FJ MIGRAINE AND THALIDOMIDE | 0 | 0 |
1123 | 3 | 10 | 369 1993 MEDICINA CLINICA 101(4):158-158 PIZARRO A; PINILLA J; GARCIATOBARUELA A THERAPY WITH THALIDOMIDE AND TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION | 0 | 1 |
1124 | 0 | 0 | 371 1993 NEW SCIENTIST 137(1862):6-6 DAYTON L THALIDOMIDE HERO FOUND GUILTY OF SCIENTIFIC FRAUD | 0 | 0 |
1125 | 0 | 9 | 373 1993 PHARMAZIE 48(2):147-148 HOFENEDER M; KREBS G; SUTTER B; KOCH HP ACUTE TOXICITY OF THALIDOMIDE, TAGLUTIMIDE AND SUPIDIMIDE IN THE YEAST-TEST | 0 | 2 |
1126 | 2 | 34 | 377 1993 SPECTROSCOPY LETTERS 26(4):597-619 ROTHCHILD R; SANDERS K; VENKATASUBBAN KS NMR-STUDIES OF DRUGS - USE OF LANTHANIDE SHIFT-REAGENTS IN POLAR-SOLVENT WITH THALIDOMIDE | 0 | 6 |
1127 | 0 | 0 | 386 1994 BLOOD 84(10):A335-A335 PARKER PM; NADEMANEE A; ODONNELL MR; SNYDER DS; STEIN A; SMITH E; MOLINA A; STEPAN DE; CHAO N; NILAND JC; BLUME KG; FORMAN SJ NEUTROPENIA IS A COMPLICATION OF THALIDOMIDE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE | 0 | 0 |
1128 | 0 | 0 | 398 1994 CHEMISTRY IN BRITAIN 30(4):280-280 CAREY J THALIDOMIDE DEBATE - REPLY | 0 | 0 |
1129 | 0 | 0 | 399 1994 CHEMISTRY IN BRITAIN 30(4):280-280 HUNT JR THALIDOMIDE DEBATE | 0 | 0 |
1130 | 0 | 0 | 401 1994 CLINICAL RESEARCH 42(2):A142-A142 RIFKIN IR; MCHUGH SM; BRADLEY JR; THIRU S; EWAN PW; LOCKWOOD CM INDUCTION OF TH2, AND INHIBITION OF TH1, LYMPHOCYTE-RESPONSES BY THALIDOMIDE | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1131 | 10 | 24 | 405 1994 FOLIA BIOLOGICA 40(4):161-171 BILA V; KREN V EVIDENCE FOR TERATOGENICITY OF THALIDOMIDE USING CONGENIC AND RECOMBINANT INBRED RAT STRAINS | 0 | 10 |
1132 | 0 | 0 | 407 1994 INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 35(4):1996-1996 DAMATO RJ; LOUGHMAN MS; FLYNN E; FOLKMAN J THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS | 0 | 0 |
1133 | 2 | 13 | 408 1994 JOURNAL OF CHEMICAL CRYSTALLOGRAPHY 24(1):95-99 CAIRA MR; BOTHA SA; FLANAGAN DR POLYMORPHISM OF N-(2,6-DIOXO-3-PIPERIDYL)PHTHALIMIDE (THALIDOMIDE) - STRUCTURAL CHARACTERIZATION OF A 2ND MONOCLINIC RACEMIC MODIFICATION | 0 | 2 |
1134 | 0 | 0 | 421 1994 PANMINERVA MEDICA 36(1):44-47 VOSGERAU JCB ATYPICAL HERPES SIMPLE - A SIGN OF TOXOPLASMOSIS ACTIVITY IN AIDS PATIENTS AND THE USE OF THALIDOMIDE | 0 | 1 |
1135 | 0 | 0 | 425 1994 REVISTA BRASILEIRA DE GENETICA 17(4):449-464 SALDANHA PH THE THALIDOMIDE-TRAGEDY AND THE BIRTH OF EXPERIMENTAL TERATOLOGY | 0 | 0 |
1136 | 0 | 0 | 437 1995 ARTHRITIS AND RHEUMATISM 38(9):769-769 SCOVILLE CD OPEN TRIAL OF THALIDOMIDE IN THE TREATMENT OF RHEUMATOID-ARTHRITIS | 0 | 0 |
1137 | 0 | 0 | 440 1995 BLOOD 86(10):1577-1577 Browne PV; Wagner J; Weisdorf DJ; DeFor T; Miller WJ; Davies SM; Filipovich A; McGlave PB; Ramsay NKC; Enright H Response to thalidomide therapy in patients with refractory chronic graft-versus-host disease. | 0 | 0 |
1138 | 0 | 0 | 444 1995 CHEMISTRY IN BRITAIN 31(10):760-760 [Anon] THALIDOMIDE REVIVAL | 0 | 0 |
1139 | 5 | 6 | 446 1995 CLINICAL AND EXPERIMENTAL DERMATOLOGY 20(1):85-85 MISERY L; PEGUETNAVARRO J; THIVOLET J; FAURE M; SCHMITT D; CLAUDY AL THALIDOMIDE DOES NOT AFFECT IN-VITRO MIXED SKIN CELL LYMPHOCYTE REACTIONS | 0 | 1 |
1140 | 0 | 0 | 453 1995 ENVIRONMENTAL HEALTH PERSPECTIVES 103(2):132-132 [Anon] RETHINKING THALIDOMIDE | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1141 | 0 | 0 | 454 1995 EUROPEAN CHEMICAL NEWS 63(1667):8-8 [Anon] GUINNESS TOPS UP THALIDOMIDE FUND | 0 | 0 |
1142 | 0 | 0 | 464 1995 INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 36(4):S225-S225 DAMATO RJ; KENYON BM FURTHER-STUDIES EXAMINING THE EFFECTS OF THALIDOMIDE ON ANGIOGENESIS | 0 | 0 |
1143 | 0 | 0 | 472 1995 KIDNEY INTERNATIONAL 47(2):672-672 RIFLKIN IR; MCHUGH SM; BRADLEY JR; THIRU S; EWAN PW; LOCKWOOD CM THALIDOMIDE AS TREATMENT FOR REFRACTORY SYSTEMIC VASCULITIS - POSSIBLE MECHANISM OF ACTION | 0 | 0 |
1144 | 0 | 0 | 477 1995 MOLECULAR BIOLOGY OF THE CELL 6:1195-1195 DESESSO JM; HARRIS SB; SCIALLI AR; GOERINGER GC EARLY MICROSCOPIC OBSERVATIONS OF THALIDOMIDE-INDUCED LIMB DEFECTS IN NEW-ZEALAND WHITE-RABBITS | 0 | 0 |
1145 | 5 | 5 | 479 1995 MOLECULAR MEDICINE TODAY 1(5):210-210 STEWART A IS THALIDOMIDE A MUTAGEN | 0 | 0 |
1146 | 1 | 1 | 483 1995 POSTGRADUATE MEDICAL JOURNAL 71(832):123-123 JUDGE MR; KOBZABLACK A; HAWK JLM GUIDELINES FOR THE CLINICAL USE AND DISPENSING OF THALIDOMIDE | 0 | 0 |
1147 | 2 | 3 | 484 1995 PRESSE MEDICALE 24(1):40-40 COUDERC LJ; MATHEZ D; LEIBOWITCH J; AUTRAN B; CAUBARRERE I PROLONGED THALIDOMIDE TREATMENT IN AN HIV-INFECTED PATIENT | 0 | 1 |
1148 | 0 | 0 | 485 1995 SEARCH 26(10):290-290 WESTMORE A HEREDITY OF THALIDOMIDE DEFORMITY DISPUTED | 0 | 0 |
1149 | 0 | 0 | 487 1996 ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 212:140-MEDI Niwayama S; Turk B; Liu J Potent inhibition of tumor necrosis factor-alpha by tetrafluoro-thalidomide and tetrafluorophthalimides | 0 | 0 |
1150 | 0 | 0 | 488 1996 AIDS 10:P60-P60 FeregrinoGoyos M; GomezCaro WH; AlvaradoDiez R; Yieyra MPM; TorrasGiner V Thalidomide and ketoprofen reduce the incidence of adverse events of interleukin 2 and enhance the antiviral activity of CD8 in HIV/AIDS patients. | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1151 | 0 | 0 | 489 1996 AIDS 10:P102-P102 MacRedmond R; Keating S; Armstrong S; Ryan M; Mulcahy FM The use of oral thalidomide in the treatment of oesophageal ulceration in AIDS. | 0 | 0 |
1152 | 0 | 0 | 491 1996 AIDS PATIENT CARE AND STDS 10(1):51-51 [Anon] Thalidomide effective in treating AIDS-related mouth ulcers | 0 | 0 |
1153 | 0 | 0 | 492 1996 AIDS PATIENT CARE AND STDS 10(4):263-263 [Anon] Thalidomide trial for diarrhea | 0 | 0 |
1154 | 0 | 0 | 493 1996 AMERICAN JOURNAL OF EPIDEMIOLOGY 143(11):6-6 Yang Q; Khoury MJ; James LM; Olney RS; Paulozzi LJ The return of thalidomide? Are birth defects surveillance systems ready? | 0 | 1 |
1155 | 1 | 2 | 503 1996 ARCHIVES OF DISEASE IN CHILDHOOD 75(1):90-90 Harry TC Thalidomide treatment of mucosal ulcerations in HIV infection | 0 | 0 |
1156 | 0 | 0 | 505 1996 ARTHRITIS AND RHEUMATISM 39(9):1352-1352 Stevens RJ; Andujar C; Edwards C; Ames PRJ; Barwick AR; Khamashta MA; Hughes GRV Thalidomide in the treatment of cutaneous manifestations of lupus erythematosus. | 0 | 1 |
1157 | 0 | 0 | 506 1996 ARTHRITIS AND RHEUMATISM 39(9):1353-1353 Sato EI; Assis LSS; Furtado R Long-term thalidomide therapy for cutaneous lesions of systemic lupus erythematosus (SLE) | 0 | 0 |
1158 | 0 | 0 | 511 1996 BLOOD 88(10):2423-2423 Flowers MED; Tapscott SJ; Emerson J; Emerson MV; Reagan T; Taylor L; Ajer T; Siadak M; Sanders J; Zwingenberger K; Willsmann K; Appelbaum F; Sullivan KM Incidence of peripheral neuropathy (PN) prior to thalidomide treatment for chronic graft-versus-host disease (GVHD). | 0 | 0 |
1159 | 0 | 0 | 512 1996 BLOOD 88(10):2424-2424 Kulkarni S; Powles R; Mehta J; Horton C; Treleaven J; Middleton G; Eisen T; Singhal S Thalidomide for acute or chronic graft-versus-host disease. | 0 | 0 |
1160 | 1 | 5 | 523 1996 ENDOSCOPY 28(5):471-472 Louvel D; Musso S; Metivier S; Croizet O; Rouquet RM; Massip P; Escourrou J; Frexinos J Idiopathic esophageal ulceration associated with human immunodeficiency virus infection: Efficacy of thalidomide treatment | 0 | 1 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1161 | 0 | 0 | 526 1996 FASEB JOURNAL 10(6):303-303 Shannon EJ; Sandoval F; Krahenbuhl J Hydrolysis of thalidomide abrogates its ability to enhance IL-2 or to suppress TNF-alpha. | 0 | 0 |
1162 | 8 | 14 | 527 1996 GASTROINTESTINAL ENDOSCOPY 44(6):729-731 Bellomo A; SchorrLesnick B Thalidomide treatment for idiopathic esophageal ulcers in patients with HIV | 0 | 1 |
1163 | 0 | 0 | 529 1996 IMMUNOLOGY 89:ORI27-ORI27 Marriott JB; Cookson S; Westby M; Guckian M; Dalgleish AG The effect of a thalidomide analogue on TNF-alpha/cytokine production in vitro | 0 | 0 |
1164 | 0 | 0 | 530 1996 IMMUNOLOGY 89:E51-E51 Guckian M; Marriott JB; Cookson S; Westby M; Dalgleish G Thalidomide analog 3052 reduces NK activity and PHA-induced proliferation in vitro. | 0 | 0 |
1165 | 0 | 0 | 536 1996 INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 37(3):546-546 Ozaki S; Yamana T; Kita M; Honda Y Effect of thalidomide on experimental choroidal neovascularization in pigmented rats | 0 | 0 |
1166 | 0 | 0 | 537 1996 INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 37(3):572-572 Tsujikawa M; Saito Y; Tatebayashi M; Tano Y The inhibitory effect of thalidomide for experimental preretinal neovascularization by laser-induced venous occlusion in rats. | 0 | 0 |
1167 | 0 | 0 | 538 1996 INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 37(3):3032-3032 Lansing MB; Dixit S; Glaser BM The effect of systemic thalidomide and amiloride on neovascularization in the rabbit corneal micropocket essay | 0 | 0 |
1168 | 0 | 0 | 539 1996 INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 37(3):4015-4015 Zhang EP; Pleyer U; Hoffmann F; Hartmann C Effect of thalidomide on experimental keratoplasty | 0 | 0 |
1169 | 0 | 0 | 548 1996 LANCET 348(9038):1370-1370 Barnett AA FDA encourages firms to test thalidomide | 0 | 0 |
1170 | 0 | 0 | 552 1996 NEUROLOGY 46(2):3015-3015 Openshaw H; Slatkin NE; Parker P Thalidomide neuropathy in bone marrow transplantation | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1171 | 0 | 0 | 553 1996 NEUROLOGY 46(2):27003-27003 Chaudhry V; Cornblath D; Corse A; Freimer M; SimmonsOBrien E; Vogelsang G Thalidomide-induced neuropathy: Clinical and electrophysiological features | 0 | 0 |
1172 | 0 | 0 | 554 1996 NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY 22(5):456-456 Chakrabarty A; Bridges LR Cerebral malformation in a patient with thalidomide related phocomelia | 0 | 0 |
1173 | 2 | 7 | 559 1996 REVISTA CLINICA ESPANOLA 196(4):270-271 Tercedor J; delaTorre ML; Rodenas JM Disseminated xanthoma with insipid diabetes: Therapeutic failure of thalidomide | 0 | 0 |
1174 | 0 | 6 | 560 1996 SLEEP 19(2):116-116 Kanbayashi T; Nishino S; Tafti M; Hishikawa Y; Dement WC; Mignot E Thalidomide, immune modulation and narcolepsy | 0 | 2 |
1175 | 5 | 51 | 561 1996 TERATOLOGY 54(3):126-134 Smith DM; Torres RD; Stephens TD Mesonephros has a role in limb development and is related to thalidomide embryopathy | 0 | 6 |
1176 | 0 | 0 | 563 1997 AIDS PATIENT CARE AND STDS 11(4):292-292 [Anon] Limited course of thalidomide effective in treating AIDS-related mouth ulcers | 0 | 0 |
1177 | 0 | 0 | 564 1997 AIDS PATIENT CARE AND STDS 11(4):292-293 [Anon] Clinical sites initiated for thalidomide aphthous ulcer study | 0 | 0 |
1178 | 0 | 0 | 565 1997 AIDS PATIENT CARE AND STDS 11(4):296-296 [Anon] Positive results reported for thalidomide in AIDS wasting | 0 | 0 |
1179 | 0 | 1 | 571 1997 AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY 54(13):1485-1486 [Anon] Thalidomide heals HIV-related oral ulcers, but caution is required | 0 | 0 |
1180 | 0 | 0 | 577 1997 ARTHRITIS AND RHEUMATISM 40(9):210-210 Hamuryudan V; Mat C; Saip S; Ozyazgan Y; Siva A; Yurdakul S; Zwingenberger K; Yazici H Randomised and placebo controlled trial of two different doses of thalidomide in Behcet's syndrome | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1181 | 0 | 0 | 579 1997 BLOOD 90(10):1673-1673 Kulkarni S; Powles R; Mehta J; Horton C; Treleaven J; Meller S; Atra A; Pinkerton CR; Singhal S Thalidomide is very effective for chronic GVHD but has no activity in acute GVHD. | 0 | 0 |
1182 | 0 | 0 | 580 1997 BLOOD 90(10):4423-4423 Mehta P; Gian VG; Smith SP; Beltz SE; Wingard JR Thalidomide is not effective for acute graft-versus-host disease. | 0 | 0 |
1183 | 2 | 5 | 581 1997 BONE MARROW TRANSPLANTATION 19(1):95-96 Chen F; Tsang K; Liang R Thalidomide-responsive chronic pulmonary GVHD | 0 | 0 |
1184 | 0 | 0 | 585 1997 CHEMISTRY & INDUSTRY (18):714-714 [Anon] Thalidomide for US | 0 | 0 |
1185 | 3 | 5 | 591 1997 CLINICAL CHEMISTRY 43(6):1095-1096 Lyon AW; Raisys VA Handling of blood samples for determination of thalidomide - Respond | 0 | 0 |
1186 | 0 | 0 | 594 1997 CLINICAL PHARMACOLOGY & THERAPEUTICS 61(2):PI44-PI44 OToole EA; Nasca MR; Palicharla P; West DP; Woodley DT Thalidomide increases keratinocyte proliferation and chemokine secretion in vitro | 0 | 0 |
1187 | 0 | 0 | 595 1997 CLINICAL PHARMACOLOGY & THERAPEUTICS 61(2):PIV89-PIV89 Donahue SR; Collins JM; Flockhart DA; Abernethy DR; Trapnell CB Thalidomide pharmacokinetics do not change with chronic administration | 0 | 0 |
1188 | 0 | 0 | 598 1997 DRUG NEWS & PERSPECTIVES 10(8):506-506 [Anon] Celgene's thalidomide approvable for ENL | 0 | 0 |
1189 | 0 | 0 | 599 1997 EUROPEAN CHEMICAL NEWS 68(1780):51-51 [Anon] Celgene - FDA approves thalidomide's use against ENL | 0 | 0 |
1190 | 0 | 0 | 601 1997 FORTUNE 136(6):36-& McLean B Thalidomide .2. | 0 | 0 |
# | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
1191 | 0 | 0 | 610 1997 INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 38(4):1240-1240 Lesk MR; Ponomarenko S; Filion B; Burnier M Effect of oral thalidomide on prolongation of rabbit sclerostomy function. | 0 | 0 |
1192 | 0 | 2 | 611 1997 INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 38(4):1680-1680 Joussen AM; Kruse FE; Becker M; Rohrschneider K; Volcker HE Thalidomide inhibits angiogenesis induced by vascular endothelial growth factor | 0 | 0 |
1193 | 0 | 0 | 612 1997 INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 38(4):4467-4467 DAmato RJ; Verheul HMW; Panigrahy D; Yuan J Combination antiangiogenic therapy with thalidomide and nonsteroidal anti-inflammatory drugs (NSAIDs) | 0 | 0 |
1194 | 0 | 0 | 613 1997 INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 38(4):5409-5409 Baatz H; Tonnessen B; Pleyer U; Hartmann C Thalidomide inhibits leukocyte-endothelium-interaction in endotoxin-induced uveitis | 0 | 0 |
1195 | 0 | 0 | 614 1997 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 278(5):379-379 Nightingale SL Workshop on thalidomide | 0 | 0 |
1196 | 0 | 0 | 619 1997 JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 99(1):679-679 James DE; Jaffarian A; Biggs DF The effects of thalidomide on TNF alpha production from guinea pig alveolar macrophages in vitro and on airways' hyperresponsiveness in vivo. | 0 | 0 |
1197 | 18 | 23 | 620 1997 JOURNAL OF AOAC INTERNATIONAL 80(4):767-773 Reepmeyer JC; Cox DC Liquid chromatographic determination of thalidomide in tablets, capsules, and raw materials | 0 | 4 |
1198 | 0 | 0 | 622 1997 JOURNAL OF INVESTIGATIVE DERMATOLOGY 108(4):179-179 Nasca MR; OToole EA; Palicharla P; West DP; Woodley DT Thalidomide increases both human keratinocyte proliferation and migration | 0 | 0 |
1199 | 0 | 0 | 623 1997 JOURNAL OF INVESTIGATIVE DERMATOLOGY 108(4):721-721 Hughes MH; Brander TR; Aronson IK; Eilers D; Fiedler BC Thalidomide therapy for discoid and systemic lupus erythematosus. | 0 | 0 |
1200 | 0 | 0 | 624 1997 JOURNAL OF INVESTIGATIVE DERMATOLOGY 108(4):797-797 Wong J; Brocato D; Kumar R The effect of thalidomide on murine hemangioendothelioma | 0 | 0 |